SEC Company Response from MILLENNIUM CELL INC (CIK 0001114872) — Jul 7, 2005
MILLENNIUM CELL INC (CIK 0001114872)
Date: July 7, 2005 · CIK: 0001114872 · Accession: 0001114872-05-000017
AI Filing Summary & Sentiment
Referenced dates: July 7, 2005
Show Raw Text
CORRESP
1
filename1.htm
SEC Response Letter dated July 7, 2005
[Millennium
Cell Letterhead]
July 7,
2005
CONFIDENTIAL
Ms.
Angela Crane
Securities
and Exchange Commission
Division
of Corporate Finance
Mail Stop
6010
450 Fifth
Street, N.W.
Washington,
D.C. 20549
Millennium
Cell Inc.--
Annual
Report on Form 10-K for the fiscal year ended December 31, 2004;
and
Current
Report on Form 8-K filed on May 2, 2005
Dear Ms.
Crane:
We are
writing in response to the comments of the staff (the “Staff”) of the
Securities and Exchange Commission (the “Commission”)
contained in your letter to Millennium Cell Inc., a Delaware corporation (the
“Company”), dated
June 28, 2005 (the “Comment
Letter”),
regarding the above-referenced periodic reports. For the convenience of the
Staff, we have restated the contents of the Comment Letter and responded to the
comments in the order set forth therein.
Form
10-K for the year ended December 31, 2004
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of
Operations, page 9
1.
We
see that you have elected to present stock based compensation expense as a
separate line item on the face of the income statement. In view of the
relative significance of this item, please expand you discussions of the
various expense categories to also discuss variances in line items
inclusive of related stock compensation charges in future
filings.
Response: The
Company notes the Staff’s comment and will draft future filings to include an
expanded discussion in more detail of the stock based compensation expense
categories, including a discussion regarding variances in line items inclusive
of related stock compensation charges.
Item
9-A - Controls and Procedures, page 17
2.
We
note that your certifying officers disclose their conclusions as to the
effectiveness of your disclosure controls and procedures “within 90 days
prior to the filing date of this annual report.” However, Item 307 of
Regulation S-K requires that your certifying officers disclose their
conclusions regarding the effectiveness of your disclosure controls and
procedures “as of the end of the period covered by the report.” Please
revise future filings accordingly.
Response: The
Company notes the Staff’s comment and in future periodic report filings will
cause its certifying officers to disclose their conclusions as to the
effectiveness of the Company’s disclosure controls and procedures as of the end
of the period covered by the applicable report.
Consolidated
Statements of Operations, page F-4
3.
We
note you present stock based compensation expense as a separate line item
on the face of your statement of operations. Revise to disclose how it is
allocated to other line items right on the face of the statement. This can
be done by parenthetically noting with the appropriate line item, like
G&A, the amount of stock compensation charge that is excluded because
it’s presented as a separate line item. Similar disclosures should
accompany your Selected Financial Data presentation on page
9.
Response:
The
Company notes the Staff’s comment and in future filings, the Company will note
the amount allocated to each department.
4.
As
a related matter, we assume that none of the stock compensation charge
would be allocated to cost of goods sold. If our assumption is not
correct, the portion of the charge should be reclassified to the cost of
sales section of the income statement. We will not object if you wish to
break it out as a separate line item within that section. Please advise or
revise in future filings.
Response:
Management has determined that none of the Company’s stock compensation charges
are required to be allocated to cost of goods sold.
5.
Please
revise future filings to show all equity issuances since inception as
required by paragraph 11(d) of SFAS 7. Please disclose the following for
each issuance:
The
date and number of shares of stock or other equity securities issued for cash
or other consideration;
The
dollar amounts assigned to the consideration received;
and
The
basis for assigning amounts to any non-cash consideration
received.
Response: The
Company notes the Staff’s comment and the Company will draft future filings in a
manner that discloses the requested information for all equity issuances since
inception.
Form
8-K filed May 2, 2005
6.
We
note that you present several non-GAAP measures, including “loss from
operations - adjusted,” “net loss - adjusted” and “net loss per share -
adjusted,” which have not been described to investors. Please note that
Instruction 2 to Item 2.02 of Form 8-K requires that when furnishing
information under this item you must provide all the disclosures required
by paragraph (c)(1)(i) of Item 10 of Regulation S-K. Please revise your
Form 8-K in future periods to include a discussion, in sufficient detail,
of the following for each
non-GAAP measure:
·
The
substantive reasons why management believes each non-GAAP measure provides
useful information to investors;
·
The
specific manner in which management uses each non-GAAP measure to conduct
or evaluate its business;
·
The
economic substance behind management’s decision to use each measure; and
·
The
material limitations associated with the use of each non-GAAP measure as
compared to the use of the most directly comparable GAAP measure and the
manner in which management compensates for these limitations when using
the non-GAAP measure.
Response: The
Company notes the Staff’s comment and the Company will draft future filings to
include the requested information in instances in which the Company is
disclosing non-GAAP measures.
In
addition, please note that the Company acknowledges that it is responsible for
the adequacy and accuracy of the disclosure in the filings; that Staff comments
or changes to disclosure in response to Staff comments in the filings reviewed
by the Staff do not foreclose the Commission from taking any action with respect
to the filing; and the Company may not assert Staff comments as a defense in any
proceeding initiated by the Commission or any person under the federal
securities law of the United States.
Please do not hesitate to contact
me ((732) 542-4000) should you wish to discuss any matter
further.
Very
truly yours,
/s/ John
D. Giolli, CPA
Chief
Financial Officer
Copies
to:
Mr. Eric
Atallah
Securities
and Exchange Commission
Division
of Corporate Finance
Mail Stop
6010
450 Fifth
Street, N.W.
Washington,
D.C. 20549